Search
Login
My Portfolios Login
TradeMachine® Login
CML Research Pro Login
Get TradeMachine®
Get CML Research
Compare Products
Home
My Portfolios
CMLViz News
Breaking
Stock
Scanner
Tear Sheet
News
Profile
Stats
Stock Chart
Pivot Points
Financial Charts
Holders
Analysts
Day Trader
Back-Tester
SPX
3,900.11
-14.04
(
-0.36%
)
Dow 30
-0.21%
QQQ
-0.72%
VIX
27.15
+0.2
(
+0.74%
)
Alpha Tau Medical Ltd
NASDAQ:DRTS 3:59:53 PM EDT
11.77
-0.18
(
-1.51%
)
Products
Alpha Tau Announces FDA Approval Of Ide To Initiate Multi-Center Pivotal Study Of Alpha Dart
Published: 06/08/2022 13:21 GMT
DRTS
Alpha Tau Medical Ltd (
DRTS
)
- Alpha Tau Announces FDA Approval of Ide to Initiate Multi-center Pivotal Study of Alpha Dart™ in Recurrent Cutaneous Scc.